Measuring Oncological Value of Exercise and Statin
Status:
Not yet recruiting
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
The aim of the study is to find out whether supervised physical exercise during cancer drug
treatment improves the effectiveness of the treatment in metastasized breast, kidney, ovarian
and prostate cancer compared to unsupervised exercise. In addition, the investigators are
investigating whether the use of atorvastatin combined with guided group exercise training
would further improve the response to cancer treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Tampere University Hospital
Collaborators:
Aalto University Tampere University University of Helsinki University of Turku